Monday, June 19, 2017 10:49:21 AM
Omni Health, Inc. Converts 62% (600 Million Common Shares) of Company Common Stock into Preferred Stock in a Capitalization Restructuring
Once this restructuring is completed, it alone should significantly increase the value of our remaining shares.
Some food for thought...
Their June 13th PR announced that Omni is projecting revenues of $10 million for the current fiscal year. Two million will come from Celeb Cream. If we assume the other $8 million comes from the pharmacy operation, which had a profit margin of roughly 10% and that Celeb Cream can attain a 20% margin...
10% x $8,000,000 = $800,000
20% x $2,000,000 = $400,000
Total Earnings = $1,200,000
$1,200,000 / 975,828,741 outstanding shares = $.00123 earnings/share (EPS)
If we use a PE ratio of 40x (the average PE of Nasdaq stocks is currently 56) this translates to 40 x $.00123 = $.0492 pps
However, once the restructuring announced on 4/3/17 is completed...
$1,200,000 / 368,938,292 outstanding shares = $.00325 EPS
40 x $.00325 = $.13 pps
By this relatively conservative calculation, Omni is worth either roughly $.05 or $.13 per share depending on the share structure.
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM